Mesoblast Ltd (ADR)
General ticker "MESO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $10.0B
Mesoblast Ltd (ADR) follows the US Stock Market performance with the rate: 50.5%.
Estimated limits based on current volatility of 13.0%: low 14.89$, high 17.81$
Factors to consider:
- Current price 74.3% above estimated high
- Earnings for 15 months up through Q1 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-06-30 to 2025-06-29
- 2023-06-30 to 2024-06-29 estimated range: [6.05$, 9.90$]
- 2024-06-29 to 2025-06-29 estimated range: [5.97$, 9.89$]
Short-term MESO quotes
Long-term MESO plot with estimates
Financial data
| YTD | 2023-06-30 | 2024-06-30 |
|---|---|---|
| Operating Revenue | $7.50MM | $5.90MM |
| Operating Expenses | $76.64MM | $64.70MM |
| Operating Income | $-69.14MM | $-58.79MM |
| Non-Operating Income | $-12.96MM | $-29.35MM |
| Interest Expense | $19.44MM | $20.66MM |
| R&D Expense | $27.19MM | $25.35MM |
| Income(Loss) | $-82.10MM | $-88.15MM |
| Taxes | $-0.21MM | $-0.19MM |
| Profit(Loss) | $-81.89MM | $-87.96MM |
| Stockholders Equity | $501.84MM | $480.36MM |
| Inventory | $0.40MM | $0.00MM |
| Assets | $669.41MM | $669.15MM |
| Operating Cash Flow | $-63.27MM | $-48.46MM |
| Capital expenditure | $0.31MM | $0.27MM |
| Investing Cash Flow | $-0.19MM | $-0.10MM |
| Financing Cash Flow | $74.50MM | $40.25MM |
| Earnings Per Share* | $-1.05 | $-0.89 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.